🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
CORONA Remedies Limited (NSE:CORONA)
India flag India · Delayed Price · Currency is INR
2,236.70
-19.50 (-0.86%)
At close: Nov 19, 2026

CORONA Remedies Revenue

CORONA Remedies had revenue of 4.41B INR in the quarter ending September 30, 2026, with 22.16% growth. This brings the company's total for the last twelve months to 15.59B, up 20.02% year-over-year. In the fiscal year ending March 31, 2026, CORONA Remedies had annual revenue of 14.03B with 17.28% growth. That makes CORONA Remedies the 18,879th largest company in the world by revenue and 1,056th in India.

Revenue (ttm)
15.59B
Revenue Growth
+20.02%
P/S Ratio
8.85
Revenue / Employee
3.03M
Employees
5,153
Market Cap
136.80B

Revenue Chart

Revenue by Geography

  • India 13.46B 95.9%
  • outside India 569.10M 4.1%
Fiscal year ended Mar 31, 2026 See the full CORONA Remedies breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202614.03B2.07B17.28%
Mar 31, 202511.96B1.82B17.94%
Mar 31, 202410.14B1.30B14.75%
Mar 31, 20238.84B2.67B43.21%
Mar 31, 20226.17B411.66M7.14%
Mar 31, 2021 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

CORONA Remedies News

More News